# Study to Assess Safety and Efficacy of Ticagrelor (AZD6140) Versus Clopidogrel in Asian/Japanese Patients With Non-ST or ST Elevation Acute Coronary Syndromes (ACS)

Study · id `cardio:ct-nct01294462` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01294462](<https://clinicaltrials.gov/study/NCT01294462>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01294462

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 801 participants.

## Technical summary

Registry record NCT01294462. Randomized; quadruple masking; primary purpose treatment. Start 2011-02 (registry gives no type); primary completion 2012-07 (actual). Results posted on 2014-05-02.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 801 participants (enrolled count; ClinicalTrials.gov record NCT01294462, source copy `cardio:ctgov-nct01294462-2014-06-27`, retrieved 2026-10-26)
- Start date: 2011-02 (registry gives no type) (ClinicalTrials.gov record NCT01294462, source copy `cardio:ctgov-nct01294462-2014-06-27`, retrieved 2026-10-26)
- Primary completion: 2012-07 (actual) (ClinicalTrials.gov record NCT01294462, source copy `cardio:ctgov-nct01294462-2014-06-27`, retrieved 2026-10-26)
- Completion: 2012-07 (actual) (ClinicalTrials.gov record NCT01294462, source copy `cardio:ctgov-nct01294462-2014-06-27`, retrieved 2026-10-26)
- Results first posted: 2014-05-02 (ClinicalTrials.gov record NCT01294462, source copy `cardio:ctgov-nct01294462-2014-06-27`, retrieved 2026-10-26)
- Countries: Japan; South Korea; Taiwan (ClinicalTrials.gov record NCT01294462, source copy `cardio:ctgov-nct01294462-2014-06-27`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01294462-2014-06-27`, retrieved 2026-10-26)

## The registry's words

- Brief title: Study to Assess Safety and Efficacy of Ticagrelor (AZD6140) Versus Clopidogrel in Asian/Japanese Patients With Non-ST or ST Elevation Acute Coronary Syndromes (ACS)
- Condition: Acute Coronary Syndrome
- Condition: Percutaneous Coronary Intervention
- Intervention (Drug): Ticagrelor
- Intervention (Drug): Clopidogrel
- Intervention (Drug): Acetylsalicylic acid ASA
- Lead sponsor: AstraZeneca
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry intervention name matches this record: Ticagrelor (`cardio:ticagrelor`)
- Registry intervention name matches this record: Clopidogrel (`cardio:clopidogrel`)
- Registry lists this organization as the lead sponsor: AstraZeneca (`cardio:astrazeneca`)

## Provenance

Content hash: 93ffdf6b97c44d674735cabf3a1f59f033ecf927b4e41fbaca6c90c582f3fae6
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
